Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials

American Journal of Medicine

Volumn 130, Issue 8, 2017, Pages 991.e1-991.e8

  Okam, Maureen M ^a   Koch, Todd A ^b   Tran, Minh Ha ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Luitpold Pharmaceuticals Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fatigue; Hemoglobin; Iron replacement therapy; Iron deficiency anemia; Oral to IV transition; Quality of life

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN; FERROUS ION; FERROUS SULFATE;

ADOLESCENT; ADULT; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FATIGUE; FATIGUE LINEAR ANALOG SCALE; FATIGUE SEVERITY SCALE; FEMALE; FERRITIN BLOOD LEVEL; FUNCTIONAL STATUS ASSESSMENT; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENTION TO TREAT ANALYSIS; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEDICATION COMPLIANCE; MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PATIENT SATISFACTION; POST HOC ANALYSIS; POSTPARTUM HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETICULOCYTE COUNT; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; TRANSFERRIN SATURATION; TREATMENT RESPONSE; UTERUS BLEEDING; AGED; ANEMIA, IRON-DEFICIENCY; BLOOD; COMPARATIVE STUDY; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; FATIGUE; FEMALE; FERRITINS; FERROUS COMPOUNDS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85019699807     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2017.03.045     Document Type: Article

References (31)

1. Hentze, M.W., Muckenthaler, M.U., Galy, B., Camaschella, C., Two to tango: regulation of Mammalian iron metabolism. Cell 142:1 (2010), 24–38.
2. Crichton, R.R., Danielson, B.G., Geisser, P., Iron Therapy with Special Emphasis on Intravenous Administration. 2008, UNI-MED, London.
3. Hurrell, R., Egli, I., Iron bioavailability and dietary reference values. Am J Clin Nutr 91:5 (2010), 1461s–1467s.
4. Nairz, M., Theurl, I., Wolf, D., Weiss, G., Iron deficiency or anemia of inflammation?: differential diagnosis and mechanisms of anemia of inflammation. Wien Med Wochenschr 166:13-14 (2016), 411–423.
5. Kassebaum, N.J., Jasrasaria, R., Naghavi, M., et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 123:5 (2014), 615–624.
6. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:9995 (2015), 743–800.
7. Camaschella, C., Iron-deficiency anemia. N Engl J Med 372:19 (2015), 1832–1843.
8. Enjuanes, C., Klip, I.T., Bruguera, J., et al. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol 174:2 (2014), 268–275.
9. Haas, J.D., Brownlie, T. 4th, Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 131:2S-2 (2001), 676S–688S discussion: 688S-690S.
10. Patterson, A.J., Brown, W.J., Powers, J.R., Roberts, D.C., Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res 9:5 (2000), 491–497.
11. Friedman, A.J., Shander, A., Martin, S.R., et al. Iron deficiency anemia in women: a practical guide to detection, diagnosis, and treatment. Obstet Gynecol Surv 70:5 (2015), 342–353.
12. El-Halabi, M.M., Green, M.S., Jones, C., Salyers, W.J. Jr., Under-diagnosing and under-treating iron deficiency in hospitalized patients with gastrointestinal bleeding. World J Gastrointest Pharmacol Ther 7:1 (2016), 139–144.
13. Lopez, A., Cacoub, P., Macdougall, I.C., Peyrin-Biroulet, L., Iron deficiency anaemia. Lancet 387:10021 (2016), 907–916.
14. Peyrin-Biroulet, L., Williet, N., Cacoub, P., Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr 102:6 (2015), 1585–1594.
15. Brugnara, C., Beris, P., Iron therapy. Beaumont, C., Béris, P., Beuzard, Y., Brugnara, C., (eds.) ESH Handbook on Disorders of Iron Metabolism, 2009, European School of Haematology, Paris, 512–528.
16. Johnson-Wimbley, T.D., Graham, D.Y., Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol 4:3 (2011), 177–184.
17. Moore, R.A., Gaskell, H., Rose, P., Allan, J., Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. BMC Blood Disord, 11, 2011, 4.
18. Okam, M.M., Koch, T.A., Tran, M.H., Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica 101:1 (2016), e6–e7.
19. Van Wyck, D.B., Martens, M.G., Seid, M.H., Baker, J.B., Mangione, A., Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 110:2 pt 1 (2007), 267–278.
20. Seid, M.H., Derman, R.J., Baker, J.B., Banach, W., Goldberg, C., Rogers, R., Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 199:4 (2008), 435–437.
21. Van Wyck, D.B., Mangione, A., Morrison, J., Hadley, P.E., Jehle, J.A., Goodnough, L.T., Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion (Paris) 49:12 (2009), 2719–2728.
22. Barish, C.F., Koch, T., Butcher, A., Morris, D., Bregman, D.B., Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials. Anemia, 2012, 2012, 172104.
23. Kulnigg, S., Stoinov, S., Simanenkov, V., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 103:5 (2008), 1182–1192.
24. McHorney, C.A., Ware, J.E. Jr., Lu, J.F., Sherbourne, C.D., The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:1 (1994), 40–66.
25. Onken, J.E., Bregman, D.B., Harrington, R.A., et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion 54:2 (2014), 306–315.
26. Wells, C.W., Lewis, S., Barton, J.R., Corbett, S., Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 12:2 (2006), 123–130.
27. Ando, K., Morita, S., Higashi, T., et al. Health-related quality of life among Japanese women with iron-deficiency anemia. Qual Life Res 15:10 (2006), 1559–1563.
28. Sobrado, C.W., Cancado, R.D., Sobrado, L.F., Frugis, M.O., Sobrado, M.F., Treatment of anemia and improvement of quality of life among patients with Crohn's disease: experience using ferric carboxymaltose. Arq Gastroenterol 52:4 (2015), 255–259.
29. Comin-Colet, J., Lainscak, M., Dickstein, K., et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J 34:1 (2013), 30–38.
30. Litton, E., Xiao, J., Ho, K.M., Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ, 347, 2013, f4822.
31. Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., Gafter-Gvili, A., The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90:1 (2015), 12–23.